AbbVie Company Description

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide.

The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn’s disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine.

In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products.

Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism.

It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; Evolveimmune Therapeutics, Inc.; Genentech, Inc.; and Tentarix Biotherapeutics, LP.

The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

AbbVie Inc.

Country	United States
Founded	2012
Industry	Drug Manufacturers - General
Sector	Healthcare
Employees	50,000
CEO	Robert Michael

Contact Details

Address: 1 North Waukegan Road North Chicago, Delaware 60064-6400 United States
Phone	847 932 7900
Website	abbvie.com

Stock Details

Ticker Symbol	ABBV
Exchange	Buenos Aires Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	ARBCOM4603M9
SIC Code	2836

Key Executives

Name	Position
Robert Michael	Chief Executive Officer
Scott Reents	Chief Financial Officer
Azita Saleki-Gerhardt	Chief Operating Officer
Elizabeth Shea	Head of Investor Relations